Abbott Laboratories company information

애보트 래브러토리스NYSE:ABT · New York Stock Exchange · Healthcare
$97.50+0.84%
2026-10-02 close

Abbott Laboratories's company information is shown as of 2026-10-02. It is a security listed on New York Stock Exchange, ticker ABT. There are 14 published related companies.

About this company

Abbott Laboratories last closed at $97.50 (+0.84%) on 2026-10-02. Listed on New York Stock Exchange.

2 gurus reporting 13F holdings — Bridgewater (founded by Ray Dalio), Soros Fund (founded by George Soros)

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F is quarterly and may be filed up to 45 days later.

Curated gurus reporting this holding

A curated subset of well-known investors — not the full institutional ownership.

Suppliers, competitors and related stocks

  • MedtronicCompetitor

    심혈관·당뇨·의료기기 전반에서 글로벌 경쟁사

  • DexcomCompetitor

    연속혈당측정기(CGM) 시장 주요 경쟁사

  • RocheCompetitor

    진단(IVD)과 당뇨 모니터링 분야 경쟁사

  • 진단·의료소모품·당뇨 관련 기기에서 경쟁

  • 의료기기·제약·진단 일부에서 광범위 경쟁

  • PhilipsCompetitor

    환자모니터링·의료기기 솔루션 경쟁사

  • Siemens HealthineersCompetitor

    진단검사·영상진단 장비에서 경쟁사

  • 진단·실험실 검사 시장에서 경쟁

  • 의료유통 채널로서 Abbott 제품의 주요 고객/유통 파트너

  • McKessonCustomer

    의료유통·도매 채널로 주요 고객/유통 파트너

  • WalmartCustomer

    소비자 건강·자가검사 제품의 대형 유통채널

  • CVS HealthCustomer

    약국·리테일 헬스 채널로 소비자 헬스 제품 판매처

  • 의료보험·헬스케어 서비스 측면에서 당뇨·진단 제품 채택 영향이 큼

  • Novo NordiskRelated theme

    당뇨 치료·혈당관리 확대로 CGM/당뇨기기 수요와 연동

Major stocks in the same sector

2026-10-03 dataset

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ $8.2B(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

Abbott Laboratories notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q